BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
BCAX
105 hedge funds and large institutions have $475M invested in Bicara Therapeutics Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 43 increasing their positions, 16 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
105
Holders Change
+13
Holders Change %
+14.13%
% of All Funds
1.41%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
33
Increased
43
Reduced
16
Closed
19
Calls
$11K
Puts
$24K
Net Calls
-$13K
Net Calls Change
-$12K
Top Buyers
| 1 |
VPC
Vestal Point Capital
New York
|
+$20.7M |
| 2 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$18.1M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.49M |
| 4 |
BlackRock
New York
|
+$7.15M |
| 5 |
Millennium Management
New York
|
+$6.65M |
Top Sellers
| 1 |
B
Braidwell
Stamford,
Connecticut
|
-$28.2M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$18.2M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$18M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$15.4M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$10.9M |
